Valuation check: XLV's ROE is 41.44%, above the sector sector average of -5.68%.
Get informed when a big investor buys or sells
+ Follow41.44%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for XLV is 41.44%. That is above the sector sector average of -5.68%. Investors often review this figure alongside SSgA Active Trust - Health Care Select Sector SPDR's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, XLV currently prints 41.44% for ROE, while the sector average sits near -5.68%. That is roughly 829.3% above the sector mean. Large gaps often invite a closer look at SSgA Active Trust - Health Care Select Sector SPDR's growth, margins, and balance sheet.
Return on Equity shows how effectively SSgA Active Trust - Health Care Select Sector SPDR converts resources into returns. At 41.44%, XLV may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting XLV's ROE (41.44%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.